Nucleic Acidbased Therapeutics Market
Nucleic Acid-based Therapeutics Market Scope:
Industry Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
Nucleic Acid-based Therapeutics Market Size and Growth
Nucleic Acid-based Therapeutics market research highlights a robust growth trajectory, driven by advancements in gene therapy and RNA-based treatments. The market size is projected to reach approximately $15 billion by 2027, reflecting increasing investment in innovative therapies and rising prevalence of genetic disorders, alongside growing demand for personalized medicine solutions. Request Sample Report
Companies Covered
(Covid 19 Impact Covered)
◍ Wave Life Sciences
◍ Imugene
◍ Caperna
◍ Phylogica
◍ Protagonist Therapeutics
◍ Benitec Biopharma
◍ EGEN
◍ BioMedica
◍ Transgene
◍ Copernicus Therapeutics
The nucleic acid-based therapeutics market features companies like Wave Life Sciences, Imugene, Caperna, and others, focusing on RNA therapies, DNA-based treatments, and gene editing. These firms innovate in therapeutic development, driving market growth.
Notable sales figures include:
- Wave Life Sciences: $12 million (2022)
- Protagonist Therapeutics: $20 million (2022)
Request Sample Report
Market Segmentation
By Application
◍ Hospitals
◍ Academic & Research Institutes
By Product
◍ Anti-Sense And Anti-Gene
◍ Short Inhibitory Sequences
◍ Gene Transfer Therapy
◍ Nucleoside Analogs
◍ Ribozymes
◍ Aptamers
Request Sample Report
Market Growth
Request Sample Report
$ X Billion USD
